Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Michael Mor

6PUBLICATIONS

41CO-AUTHORS

Predictive and prognostic markersHaematologyNanomaterialsBiologically active moleculesInnate immunity

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (6)

Sort by Publication Date:

|Mar 25, 2026

Monoclonal antibodies from COVID-19 convalescent patients target cryptic epitopes for broad SARS-CoV-2 neutralization.

Aakanksha Harit, Michael Mor, Ron Yefet

|Jun 30, 2025

The GATE glycoprotein complex enhances human cytomegalovirus entry in endothelial cells.

Michael J Norris, Lauren A Henderson, Mohammed N A Siddiquey

|Aug 08, 2024

Intranasal Multiepitope PD-L1-siRNA-Based Nanovaccine: The Next-Gen COVID-19 Immunotherapy.

Rita C Acúrcio, Ron Kleiner, Daniella Vaskovich-Koubi

|Aug 05, 2022

Conformational flexibility in neutralization of SARS-CoV-2 by naturally elicited anti-SARS-CoV-2 antibodies.

Ruofan Li, Michael Mor, Bingting Ma

|Jul 27, 2022

Anti-TNFα Treatment Impairs Long-Term Immune Responses to COVID-19 mRNA Vaccine in Patients with Inflammatory Bowel Diseases.

Keren Masha Rabinowitz, Michal Navon, Hadar Edelman-Klapper

|Feb 11, 2021

Multi-clonal SARS-CoV-2 neutralization by antibodies isolated from severe COVID-19 convalescent donors.

Michael Mor, Michal Werbner, Joel Alter

Pageof 1

Frequent Collaborators

4 joint publications

Moshe Dessau

3 joint publications

Natalia T Freund

2 joint publications

Alex E Clark

2 joint publications

Aaron F Carlin

2 joint publications

Ben A Croker

2 joint publications

Meital Gal-Tanamy

1 joint publications

Elad Chomsky

1 joint publications

Ksenia Polonsky

1 joint publications

Lee S Izhaki-Tavor

1 joint publications

Dor Rafael

Frequent Collaborators

4 joint publications

Moshe Dessau

3 joint publications

Natalia T Freund

2 joint publications

Alex E Clark

2 joint publications

Aaron F Carlin

Top Related Videos

Detection of SARS-CoV-2 Neutralizing Antibodies using High-Throughput Fluorescent Imaging of Pseudovirus Infection

Detection of SARS-CoV-2 Neutralizing Antibodies using High-Throughput Fluorescent Imaging of Pseudovirus Infection

Published on : Jun 05, 2021

Production of Pseudotyped Particles to Study Highly Pathogenic Coronaviruses in a Biosafety Level 2 Setting

Production of Pseudotyped Particles to Study Highly Pathogenic Coronaviruses in a Biosafety Level 2 Setting

Published on : Mar 01, 2019

Preparation, Characteristics, Toxicity, and Efficacy Evaluation of the Nasal Self-Assembled Nanoemulsion Tumor Vaccine <em>In Vitro</em> and <em>In Vivo</em>

Preparation, Characteristics, Toxicity, and Efficacy Evaluation of the Nasal Self-Assembled Nanoemulsion Tumor Vaccine <em>In Vitro</em> and <em>In Vivo</em>

Published on : Sep 28, 2022

See more related videos

Top Related Videos

Detection of SARS-CoV-2 Neutralizing Antibodies using High-Throughput Fluorescent Imaging of Pseudovirus Infection

Detection of SARS-CoV-2 Neutralizing Antibodies using High-Throughput Fluorescent Imaging of Pseudovirus Infection

Published on : Jun 05, 2021

Production of Pseudotyped Particles to Study Highly Pathogenic Coronaviruses in a Biosafety Level 2 Setting

Production of Pseudotyped Particles to Study Highly Pathogenic Coronaviruses in a Biosafety Level 2 Setting

Published on : Mar 01, 2019

Preparation, Characteristics, Toxicity, and Efficacy Evaluation of the Nasal Self-Assembled Nanoemulsion Tumor Vaccine <em>In Vitro</em> and <em>In Vivo</em>

Preparation, Characteristics, Toxicity, and Efficacy Evaluation of the Nasal Self-Assembled Nanoemulsion Tumor Vaccine <em>In Vitro</em> and <em>In Vivo</em>

Published on : Sep 28, 2022

See more related videos